Vincristine attenuates doxorubicin cardiotoxicity

Biochemical and Biophysical Research Communications

Volumn 373, Issue 4, 2008, Pages 555-560

  Chatterjee, Kanu ^a,c   Zhang, Jianqing ^b   Tao, Rong ^b   Honbo, Norman ^b   Karliner, Joel S ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardiac myocytes; Cell culture; Doxorubicin; Signal transduction; Vincristine

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; CYTOCHROME C; DOXORUBICIN; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR; TIOPRONIN; TRYPAN BLUE; VINCRISTINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIOTOXICITY; CELL SURVIVAL; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME ACTIVATION; HEART MUSCLE CELL; HEART MUSCLE NECROSIS; HEART PROTECTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALVAGE THERAPY; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL SURVIVAL; CHROMONES; CYTOCHROMES C; CYTOPROTECTION; DOXORUBICIN; FLAVONOIDS; HUMANS; MALE; MICE; MICE, INBRED C57BL; MORPHOLINES; MYOCYTES, CARDIAC; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; VINCRISTINE;

VINCA;

EID: 50949089898     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.06.067     Document Type: Article

References (15)

1. Weiss R.B. The anthracyclines: will we ever find a better doxorubicin?. Semin. Oncol. 19 (1992) 670-686
2. Takemura G., and Fujiwara H. Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management. Prog. Cardiovasc. Dis. 49 (2007) 330-352
3. Oliveira P.J., Bjork J.A., Santos M.S., Leino R.L., Froberg M.K., Moreno A.J., and Wallace K.B. Carvedilol mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity. Toxicol. Appl. Pharmacol. 200 (2004) 159-168
4. Della Torre P., Imondi A.R., Bernardi C., Podestà A., Moneta D., Riflettuto M., and Mazué G. Cardioprotection by dexrazoxane in rats treated with doxorubicin and paclitaxel. Cancer Chemother. Pharmacol. 44 (1999) 138-142
5. Li L., Takemura G., Li Y., Miyata S., Esaki M., Okada H., Kanamori H., Khai N.C., Maruyama R., Ogino A., Minatoguchi S., Fujiwara T., and Fujiwara H. Preventive effect of erythropoietin on cardiac dysfunction in doxorubicin-induced cardiomyopathy. Circulation 113 (2006) 535-543
6. Chatterjee K., Zhang J., Honbo N., Simonis U., Shaw R., and Karliner J.S. Acute vincristine pretreatment protects adult mouse cardiac myocytes from oxidative stress. J. Mol. Cell. Cardiol. 43 (2007) 327-336
7. Zhang J., Honbo N., Goetzl E.J., Chatterjee K., Karliner J.S., and Gray M.O. Signals from type 1 sphingosine 1-phosphate receptors enhance adult mouse cardiac myocyte survival during hypoxia. Am. J. Physiol. Heart Circ. Physiol. 293 (2007) H3150-H3158
8. Bronchud M.H., Margison J.M., Howell A., Lind M., Lucas S.B., and Wilkinson P.M. Comparative pharmacokinetics of escalating doses of doxorubicin in patients with metastatic breast cancer. Cancer Chemother. Pharmacol. 25 (1990) 435-439
9. Dorr R.T., and Von Hoff D.D. Vincristine Sulfate. Cancer Chemotherapy Handbook. 2nd ed. (1994), Appleton & Lange, East Norwalk, Conn pp. 951-957
10. Gronninger E., Koopmans P., Kamps W., de Graaf S., and Uges D. An automated HPLC method to determine intracellular vincristine concentrations in mononuclear cells of children with acute lymphoblastic leukemia. Ther. Drug Monit. 25 (2003) 441-446
11. el-Missiry M.A., Othman A.I., Amer M.A., and Abd el-Aziz M.A. Attenuation of the acute adriamycin-induced cardiac and hepatic oxidative toxicity by N-(2-mercaptopropionyl) glycine in rats. Free Radic. Res. 35 (2001) 575-581
12. Hausenloy D.J., Mocanu M.M., and Yellon D.M. Cross-talk between the survival kinases during early reperfusion: its contribution to ischemic preconditioning. Cardiovasc. Res. 63 (2004) 305-312
13. Sawyer D.B., Fukazawa R., Arsttall M.A., and Kelly R.A. Daunorubicin-induced apoptosis in rat cardiac myocytes is inhibited by dexrazoxane. Circ. Res. 84 (1999) 257-265
14. Chua C.C., Liu X., Gao J., Hamdy R.C., and Chua B.L. Multiple actions of pifithrin-α on doxorubicin-induced apoptosis in rat myoblastic H9c2 cells. Am. J. Physiol. Heart Circ. Physiol. 290 (2006) H2606-H2613
15. van Wijk S.J., and Hageman G.J. Poly (ADP-ribose) polymerase-1 mediated caspase-independent cell death after ischemia/reperfusion. Free Radic. Biol. Med. 39 (2005) 81-90